Model identifies genes that induce normal skin cells to become abnormal
Main Category: Melanoma / Skin CancerAlso Included In: Dermatology
Article Date: 18 Nov 2005 - 0:00 PDT
| Patient / Public: | ![]() |
2 (4 votes) |
| Healthcare Prof: | ![]() |
Northwestern University researchers have developed a novel, three-dimensional model that allows scientists to observe how interacting with the microenvironment of metastatic melanoma cells induces normal skin cells to become similar to aggressive cancer cells that migrate and spread throughout the body.
The model, developed by Mary J. C. Hendrix and colleagues at Children's Memorial Research Center, consists of a three-dimensional collagen matrix preconditioned by malignant melanoma cells. Hendrix is president and scientific director of the Children's Memorial Research Center, professor of pediatrics at Northwestern University Feinberg School of Medicine and a member of the executive committees of The Robert H. Lurie Comprehensive Cancer Center and the Center for Genetic Medicine at Northwestern University.
The model was described in an article in the Nov. 15 issue of Cancer Research.
"Our findings offer new insights into the influence of the tumor cell microenvironment on the transformation of normal skin cells, as well as on genetic triggering mechanisms and signaling pathways that could be targeted for novel therapeutic strategies to inhibit the spread of melanoma," Hendrix said.
Metastatic cancer cells are characterized by increased tumor cell invasion and migration, as well as an undifferentiated, or "plastic," nature.
The Hendrix lab has hypothesized that this poorly differentiated cell type serves as an advantage to aggressive cancer cells by enhancing their ability to metastasize virtually undetected by the immune system. The group's current study tested the hypothesis that the microenvironment of metastatic melanoma cells could induce benign skin cells to become cancer-like.
The researchers seeded a particularly aggressive form of human metastatic melanoma cells onto a three-dimensional collagen matrix and allowed the cells to precondition the microenvironment for several days. The malignant melanoma cells were removed and the matrix was left intact.
Then, normal human skin cells were seeded onto the melanoma-preconditioned matrix and were allowed to remain for several days.
After this period, the previously normal cells seeded onto the matrix preconditioned by the metastatic melanoma were reprogrammed to express genes (produce specific gene proteins) associated with a highly plastic cell type similar to the aggressive melanoma cells used in the study.
Removal of the "transdifferentiated" skin cells from the melanoma microenvironment caused the cells to revert to their original appearance.
"There were no significant genetic changes between normal skin cells grown on an untreated matrix and those exposed to a matrix preconditioned by human metastatic melanoma cells, further supporting the hypothesis that "epigenetic" induction of changes in skin cell gene expression is directly related to exposure to the metastatic microenvironment," the authors said.
Hendrix's co-researchers on the study were Elizabeth A. Seftor; Kevin M. Brown; Lynda Chin; Dawn A. Kirshmann; William W. Wheaton; Alexei Protopopov; Bin Feng; Yoganand Balagurunathan; Jeffrey M. Trent; Brian J. Nickoloff; and Richard E. B. Seftor, from Northwestern University; Harvard Medical School; Tgen; and Loyola University.
This research was supported by grants from the National Institutes of Health/National Cancer Institute (CA59702); the Michael Sweig Foundation; and the Mazza Foundation, as well as NIH grants CA93947; CA59327; and CA27502.
Elizabeth Crown
e-crown@northwestern.edu
Northwestern University
http://www.northwestern.edu
Visit our melanoma / skin cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/33696.php>
APA
http://www.medicalnewstoday.com/releases/33696.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




